Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4138
First IPO Date
January 01, 2001
| Name | Title | Pay | Year Born |
| Terukazu Kato | President, Chief Executive Officer & Chairman | 119M | 1963 |
| Shoichi Kumagai | GM of Production Division & Executive Officer | 0 | N/A |
| Kaoru Kobayashi | Chief Financial Officer & Head of the Corporate Management Division | 0 | N/A |
| Toshio Yamaoka | Executive Officer and Head of Pharmaceutical Sales & Marketing Division | 0 | N/A |
| Kei Sugii | COO & Director | 0 | 1969 |
| Zhang Lixian | Executive Officer & China Production Manager and China Pharmaceutical Platform Manager | 0 | N/A |
| Kouji Shiseki | Executive Officer & Head of Corporate Secretary Division | 0 | N/A |
| Yoshiharu Watanabe | Executive Officer & Chinese Herbal Medicine Platform Director | 0 | N/A |
| Akihito Konda | Chief Technology Officer and Head of Research & Development Division | 0 | N/A |
| Makoto Kitamura | Head of Corporate Communications Dept. | 0 | N/A |
Established in Tokyo, Japan, in 1893, Tsumura & Co. operates worldwide in the pharmaceutical sector. The company's core business involves the creation and international distribution of various medicinal products, with a particular focus on Kampo extract intermediates and granular Kampo preparations. Its operations are comprehensive, encompassing the full supply chain: from the careful acquisition, selection, processing, and warehousing of raw herbal materials and crude drug components for decoctions, to the manufacturing of powdered Kampo extracts and traditional Chinese medicines. Additionally, Tsumura & Co. is engaged in the sale of both pharmaceutical goods and food products.